Galleria mellonella

Galleria mellonella, commonly known as the wax moth, is a small insect larva that has become one of the most important experimental organisms in modern biological research. Originally infamous as a pest that damages beehives by consuming beeswax, this humble caterpillar has been repurposed as a powerful scientific tool for studying disease, immunity, and drug development. The larvae are typically just a few centimeters long, with a cream-colored body and the ability to survive in laboratory conditions with minimal care and cost.

Galleria mellonella larvae appear across multiple scientific disciplines including microbiology, immunology, toxicology, and pharmacology, particularly in research institutions worldwide. Scientists value these insects because they share fundamental immune system components with humans while being ethically simpler to study than vertebrate animals, making them an ideal bridge between test-tube experiments and animal models. The larvae have become especially crucial in testing the virulence of bacterial pathogens, evaluating antibiotic resistance, and screening new drug candidates before they advance to mammalian testing.

The wax moth larva functions as a miniature model organism through its sophisticated immune system, which can mount responses to infections similar to how human immune cells react to pathogens. When researchers inject bacteria or fungi into the larvae, they can observe whether the insect's immune defenses defeat the invader, and measure survival rates to determine how dangerous a pathogen is or how effective a new drug might be. This process is analogous to how a simplified computer simulation can predict how a complex real-world system will behave, but using living biology instead of code.

Galleria mellonella has become indispensable in identifying new antibiotics and understanding why certain infections resist current treatments, which directly addresses the global crisis of antibiotic-resistant bacteria. Beyond infectious disease, researchers use these larvae to test the safety and efficacy of experimental cancer drugs, nanoparticles, and other therapeutics, potentially accelerating the path from laboratory discovery to human treatment while reducing the number of traditional animal models needed in research.